Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis.
Intern Med J
; 44(12a): 1245-6, 2014 Dec.
Article
em En
| MEDLINE
| ID: mdl-25442759
ABSTRACT
Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei and can present with severe sepsis. Predisposing risk factors are present in 80% of cases. Monoclonal antibodies are increasingly prescribed for varied medical conditions. This report describes the first known case of melioidosis in a patient whose only risk factor for disease is treatment with a monoclonal antibody. Prescribers of monoclonal antibodies and other immunosuppressants should ensure that their patients are aware of the potential risk of melioidosis prior to travel and the precautions that should be taken.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Artrite Psoriásica
/
Antirreumáticos
/
Combinação Amoxicilina e Clavulanato de Potássio
/
Anticorpos Monoclonais Humanizados
/
Melioidose
/
Anti-Infecciosos
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Intern Med J
Assunto da revista:
MEDICINA INTERNA
Ano de publicação:
2014
Tipo de documento:
Article
País de afiliação:
Austrália